Calls
Source: S&P Capital IQ transcripts via Xpressfeed · latest indexed call 2026-05-07 · generated 2026-08-03.
Latest call digest
Maximus, Inc., Q2 2026 Earnings Call, May 07, 2026 · 2026-05-07T13:00:00
Q2 FY2026 — May 7, 2026. Prepared remarks led with margin, not growth. Revenue was $1.31 billion, flat against guidance and down against a prior-year quarter that carried natural disaster work and elevated clinical volumes; adjusted EBITDA margin was 14.4% and adjusted EPS $2.07, versus 13.7% and $2.01 a year earlier. Two offsetting one-offs ran through the quarter: a $6.9 million non-cash impairment of a capitalized software asset in U.S. Services ($0.09), and a $4.2 million discrete R&D tax credit (roughly $0.08). CFO David Mutryn raised full-year adjusted EPS guidance by $0.20 to $8.25–$8.55 — the second consecutive raise — lifted the EBITDA margin guide to approximately 14.2%, reiterated revenue of $5.2–$5.35 billion and free cash flow of $450–$500 million, and raised the near-term EBITDA margin target range from 10%–13% to 12%–15%. The Board refreshed the buyback for up to $400 million effective May 11, after $111 million of repurchases in the quarter and $40 million more through May 1.
The Q&A reality was narrower than the prepared remarks. Only one analyst asked questions — Will Gildea of CJS Securities — and his line of inquiry was less about the raise than about the two soft spots. First, cash: DSO stayed at 78 days on administrative delays at a single major federal customer, the same customer behind the FY2025 build; management expects AR to stay roughly flat in Q3 before declining in Q4, and expanded its receivables purchase agreement ceiling from $250 million to $350 million. Second, the divergence between segments: U.S. Federal Services margin reached 17.6% while U.S. Services printed 9.3% (10.9% excluding the impairment) on revenue down to $416 million from $442 million. Asked directly why technology leverage shows up in one segment and not the other, CEO Bruce Caswell gave the most substantive answer of the call — larger federal contract scale, state customers expressing caution on AI adoption without guardrails, multiple legacy-system integration points, and limited state bandwidth ahead of HR-1 implementation.
What was actually committed: U.S. Services returning to mid-single-digit organic growth in Q4, DSO finishing the year below 70 days, full-year segment margins of approximately 17.5% for U.S. Federal Services and approximately 10.0% for U.S. Services, and roughly breakeven Outside the U.S. Awards remain thin — year-to-date signed contract value of $913 million and a book-to-bill of approximately 0.5x, with the quarterly figure improving to 0.5x from 0.2x. The HR-1 story advanced qualitatively rather than contractually: two states working toward arrangements under existing contracts, one of which management estimates could lift current program revenue by more than 30%, and an HR-1-related pipeline set up 75% quarter over quarter — but final work-requirement regulations are still expected next quarter. The VA medical disability exam recompete, the single largest contract event ahead, has no published timeline; the current contract runs through December 31, 2026.
Participant coverage from the latest call.
| Group | Participants | Count |
|---|---|---|
| Management | Operator; James Francis — Vice President of Investor Relations, Maximus, Inc.; David Mutryn — CFO & Treasurer, Maximus, Inc.; Bruce L. Caswell — President, CEO & Director, Maximus, Inc. | 4 |
| Analysts | Will Gildea — Equity Research Associate, CJS Securities, Inc. | 1 |
Curated latest-call exchanges; one row per analyst topic.
| Analyst | Firm | Topic | What changed in Q&A |
|---|---|---|---|
| Will Gildea | CJS Securities, Inc. | Elevated DSO and buyback capacity | Mutryn traced the 78-day DSO to one major federal customer with complex, partly retroactive invoicing requirements — the same customer that drove the FY2025 build — and said AR there may stay flat in Q3 before declining in Q4. He framed repurchase sizing as a function of near-term liquidity, valuation and the M&A opportunity set rather than a fixed pace. |
| Will Gildea | CJS Securities, Inc. | SNAP offerings beyond Accuracy Assistant | Caswell described the Accuracy Assistant tool as the core, with BPO services wrapped around it to contact beneficiaries and correct data, plus a separate Medicaid community engagement tool covering exemptions, appeals and mobile evidence submission. No revenue sizing or contract timing was offered. |
| Will Gildea | CJS Securities, Inc. | Why U.S. Services revenue fell, and confidence in a Q4 turn | Mutryn attributed the decline to higher prior-year clinical work and state-specific volume dynamics on one larger clinical contract, saying it was not indicative of a broader trend. Confidence in Q4 rests specifically on HR-1-related activity arriving in that quarter — an outcome dependent on regulations not yet final. |
| Will Gildea | CJS Securities, Inc. | Federal margin keeps rising while U.S. Services does not | The hardest exchange of the call. Caswell gave four reasons: federal contracts are larger so automation scales further; state customers deliver services directly to consumers and are more cautious on AI without guardrails; state programs require integration across multiple legacy systems (one state trains staff across five); and states have limited bandwidth and budget while implementing HR-1. |
| Will Gildea | CJS Securities, Inc. | VA recompete timing and Industry Day | Caswell said the current contract runs through December 31, 2026 for all vendors and that the VA has not released a formal rebid timeline; he expects to learn more at the upcoming Industry Day and noted agencies generally can extend contracts while completing a recompete, without saying whether the VA intends to. |
| Will Gildea | CJS Securities, Inc. | Remaining tough federal comparisons | Mutryn flagged the June FY2025 quarter as another tough comp on the surge in clinical volumes, with Q4 a tough comp to a lesser extent. Caswell separately said no recompete other than the veterans exam work warrants calling out, and that rebid determinations moving right can extend incumbent work. |
Theme tracker
Themes are curator-classified across supplied calls.
| Theme | Status | Quarters mentioned | Read-through |
|---|---|---|---|
| AI and automation as the stated source of margin expansion | persisted | Q3 2023, Q4 2023, Q1 2024, Q2 2024, Q3 2024, Q4 2024, Q1 2025, Q2 2025, Q3 2025, Q4 2025, Q1 2026, Q2 2026 | Present in every call in the supplied history, but the framing has moved from governance and pilots (AI Governance Board in Q3 2023, Agent Assist pilots in Q1 2024) to quantified operating leverage — 45% of disputes resolved autonomously on one program in Q1 2026, nearly half the claim-processing effort automated by Q2 2026. This is the mechanism management now points to for the federal segment margin going from 12.2% in FY2024 to a ~17.5% full-year guide. |
| HR-1 / One Big Beautiful Bill Act — Medicaid work requirements and SNAP error rates | emerged | Q3 2025, Q4 2025, Q1 2026, Q2 2026 | First raised on the August 2025 call and now the central growth argument for U.S. Services. The revenue date has stayed stubbornly forward: initially framed as an FY2027 driver, then as high-single to low-double-digit organic uplift layering in over FY2027 into FY2028. Q2 2026 is the first call to point to specific states and an existing-contract mechanism, but final regulations are still pending. |
| Volume moderation from an unusually strong prior year | persisted | Q3 2024, Q4 2024, Q1 2025, Q4 2025, Q1 2026, Q2 2026 | The specific source rotates — Medicaid unwinding excess volumes through FY2024, then clinical surge and natural disaster support through FY2025 — but the pattern is the same: an unforecastable volume benefit lands, guidance is raised, and the following year is spent explaining the comp. Management sized the FY2025 natural disaster work at roughly $100 million on the Q1 2026 call. |
| Weak book-to-bill and slow procurement adjudication | persisted | Q3 2024, Q4 2024, Q1 2025, Q2 2025, Q3 2025, Q4 2025, Q1 2026, Q2 2026 | Trailing-twelve-month book-to-bill has been below 1.0x across the entire window — 0.4x in FY2024, recovering to 0.9x at September 30, 2025, then back to 0.5x in both FY2026 quarters after a shutdown-affected Q1. Management consistently attributes this to rebid timing rather than win rates, and FY2026 guidance assumes virtually no contribution from new work. |
| Collections, DSO and working-capital strain | persisted | Q2 2025, Q3 2025, Q4 2025, Q1 2026, Q2 2026 | DSO ran 73 days, then peaked at 96 days in Q3 2025, dropped to 62 days at fiscal year-end after catch-up collections, then rebuilt to 78 days in both FY2026 quarters. The recurrence at the same major federal customer, and the expansion of the receivables purchase facility ceiling to $350 million, make this a structural feature of the story rather than a one-quarter timing item. |
| Defense and national security as a new growth vector | emerged | Q4 2024, Q3 2025, Q4 2025, Q1 2026, Q2 2026 | Started with a small DoD AI contract in FY2024 and built through CMMC Level 2 certification, a $77 million Air Force award, an $86 million follow-on, a CRADA and expanded use of other transaction authorities. It is also now the stated bias for M&A. Contract values so far are small relative to a $5.3 billion revenue base. |
| CMS contact center recompete and the labor harmony dispute | dropped | Q1 2024, Q2 2024, Q3 2024, Q4 2024, Q1 2025 | Dominated four consecutive calls — GAO protest, Court of Federal Claims suit, a $6.6 billion pipeline entry — and then disappeared entirely once the government cancelled the procurement in late 2024, clearing the contract to run through 2031 on option periods. Its absence since Q1 2025 removes what had been the single largest identified contract risk. |
| DOGE and federal cost-cutting exposure | dropped | Q4 2024, Q1 2025, Q2 2025, Q3 2025 | A standing agenda item across four calls, sized by management at roughly $4 million of FY2025 revenue and later at under 0.5% of FY2025 revenue. It has not been raised since August 2025; the federal risk discussion has shifted to shutdown effects and acquisition-workforce shortages. The disappearance reads as the risk resolving small rather than as an unanswered question. |
Guidance ledger
Quotes, calls, and speakers are source-verified; outcomes are curator-classified.
| Verbatim guidance | Call | Speaker | Curator outcome | Outcome note |
|---|---|---|---|---|
| “Adjusted EPS, excluding intangibles, amortization and divestiture-related charges, is now projected to be between $6 and $6.20 per share.” | Maximus, Inc., Q3 2024 Earnings Call, Aug 08, 2024 · 2024-08-08T13:00:00 | David Mutryn | kept | The November 2024 call reported full-year FY2024 adjusted EPS of $6.11, inside the range. |
| “For fiscal 2025, revenue is projected to be between $5.275 billion and $5.425 billion. Adjusted EBITDA margin is estimated to be approximately 11%, and adjusted EPS is projected to be between $5.70 and $6 per share.” | Maximus, Inc., 2024 Earnings Call, Nov 21, 2024 · 2024-11-21T14:00:00 | David Mutryn | kept | FY2025 finished at $5.43 billion of revenue, a 12.9% adjusted EBITDA margin and $7.36 adjusted EPS per the November 2025 call — revenue at the top of the range and margin and EPS well above it, after three in-year raises. |
| “our adjusted EPS guide increases by $0.20 to range between $5.90 and $6.20 per share.” | Maximus, Inc., Q1 2025 Earnings Call, Feb 06, 2025 · 2025-02-06T14:00:00 | David Mutryn | kept | Superseded by two further raises in the same year; FY2025 adjusted EPS was $7.36. |
| “Our adjusted EPS guidance increases by $0.40 to range between $6.30 and $6.60 per share.” | Maximus, Inc., Q2 2025 Earnings Call, May 08, 2025 · 2025-05-08T13:00:00 | David Mutryn | kept | Raised again in August 2025 to $7.35–$7.55 and delivered at $7.36 for the full year. |
| “We are raising our free cash flow guidance to between $370 million and $390 million.” | Maximus, Inc., Q3 2025 Earnings Call, Aug 07, 2025 · 2025-08-07T13:00:00 | David Mutryn | missed | The November 2025 call reported FY2025 free cash flow of $366 million, below the raised range, despite $642 million of free cash flow in the fourth quarter alone. |
| “our guidance assumes that we will collect the $224 million now billed related to that contract prior to September 30, 2025.” | Maximus, Inc., Q3 2025 Earnings Call, Aug 07, 2025 · 2025-08-07T13:00:00 | David Mutryn | kept | DSO fell from 96 days to 62 days at September 30, 2025, which the November 2025 call attributed to catching up collections on the two contracts that had driven the elevated balance. |
| “For fiscal 2026, revenue is projected to be between $5.225 billion and $5.425 billion with a midpoint of $5.325 billion. Adjusted EBITDA margin is estimated to be approximately 13.7%, and adjusted EPS is projected to be between $7.95 and $8.25 per share” | Maximus, Inc., Q4 2025 Earnings Call, Nov 20, 2025 · 2025-11-20T14:00:00 | David Mutryn | pending | Revenue was narrowed to $5.2–$5.35 billion in February 2026 for a divestiture and new-work timing; margin and EPS have since been raised twice, to approximately 14.2% and $8.25–$8.55. |
| “We expect the U.S. Federal Services margin to range between 16.5% and 17%, a 100 basis point improvement from prior guidance.” | Maximus, Inc., Q1 2026 Earnings Call, Feb 05, 2026 · 2026-02-05T14:00:00 | David Mutryn | pending | Raised again in May 2026 to approximately 17.5% for the full year; the segment printed 17.6% in the second quarter. |
| “Our adjusted EPS guidance increases by $0.20 and is now expected to range between $8.25 and $8.55 per share.” | Maximus, Inc., Q2 2026 Earnings Call, May 07, 2026 · 2026-05-07T13:00:00 | David Mutryn | pending | Management describes the midpoint as 14% year-over-year growth. FY2026 is not complete in the supplied call history. |
| “we expect collections to accelerate and thus DSO to trend downward and finish fiscal year 2026 below 70 days” | Maximus, Inc., Q2 2026 Earnings Call, May 07, 2026 · 2026-05-07T13:00:00 | David Mutryn | pending | Management expects DSO to remain elevated at June 30 and improve in the fourth quarter; the $450–$500 million free cash flow guide depends on this. |
| “we are raising our near-term adjusted EBITDA margin target range to 12% to 15%” | Maximus, Inc., Q2 2026 Earnings Call, May 07, 2026 · 2026-05-07T13:00:00 | David Mutryn | pending | Replaces the 10%–13% range set on the November 2024 call. Management says it expects to operate toward the upper end in periods with stable volumes, while noting new program ramps and mix can affect any given year. |
Q&A pressure map
Question counts and firms are curator tallies; analyst coverage shown above.
| Topic | Questions | Firms | Pressure / response |
|---|---|---|---|
| VA medical disability exams — volumes, capacity and the recompete | 15 | Stifel, Nicolaus & Company, Incorporated, Research Division, CJS Securities, Inc., Raymond James & Associates, Inc., Research Division | The most persistently pressed topic in the window, and the one where analysts have pushed back hardest on management's own framing. Brian Gesuale of Raymond James twice challenged the volume outlook directly — arguing in August 2025 that the comps looked easy given industry-wide added capacity, and pressing in February 2026 on whether the shutdown slowed the VA's push of cases to vendors. Management conceded the first point in part and held firm on the second. |
| U.S. Services revenue decline and the path back to growth | 7 | CJS Securities, Inc., Raymond James & Associates, Inc., Research Division | Concentrated in the two FY2026 calls. Analysts have repeatedly asked how transitory the lower volumes are, whether the segment can grow for the year, and what drives the promised Q4 turn. Management's answers have been consistent — seasonality and contract structure, not a population or demand trend — but the return to growth has stayed one or two quarters ahead throughout. |
| Sizing and timing of the HR-1 / OBBBA opportunity | 7 | CJS Securities, Inc., Raymond James & Associates, Inc., Research Division | Analysts have asked for quantification on every call since August 2025. The most specific answer came in February 2026: a high-single to low-double-digit organic growth opportunity for U.S. Services, layering in over FY2027 and FY2028. Management has been candid that the estimate carries a multitude of assumptions. |
| Federal policy disruption — DOGE, shutdown and procurement delays | 6 | CJS Securities, Inc., Raymond James & Associates, Inc., Research Division | Pressed on every call from November 2024 through November 2025. Management quantified the exposure early and repeatedly — roughly $4 million of FY2025 revenue from DOGE actions, later restated as under 0.5% of FY2025 revenue, and fewer than a dozen of nearly 40,000 employees affected by shutdown funding curtailments. The topic has not been raised since. |
| Cash conversion, DSO and capital deployment | 4 | CJS Securities, Inc., Raymond James & Associates, Inc., Research Division | Asked less often than the operating topics but consistently at the points where cash and buybacks interact. On the latest call this was the opening question, pairing the elevated DSO with the refreshed authorization — a fair read that the buyback is being funded against collections that have not yet arrived. |
| Segment-level guidance detail | 3 | CJS Securities, Inc. | Worth flagging as a limit on disclosure rather than evasion. Asked in August 2025 for a Q4 revenue split by segment, Mutryn said plainly that it was too early and that he was hesitant to give segment-level guidance at that stage. Segment revenue guidance has not been provided since; only segment operating margin ranges are given. |
Language shifts
Only language evidence verified against the referenced component is shown.
| Observation | Verbatim evidence | Call ID | Component |
|---|---|---|---|
| First program-level write-off language in the window. After several quarters in which the only adjustments were divestiture charges and severance, Q2 FY2026 introduced a customer-decision-driven impairment of previously capitalized software — a reminder that capitalized technology spend carries realization risk when a contract changes. | “A recent decision by this customer led us to writing off the balance of the asset, which was $6.9 million or $0.09 per share impact to the U.S. Services segment operating income.” | 1994106528 | 2 |
| New caution vocabulary attached to AI, and pointed at customers rather than the company. Across ten prior calls AI was described only as an opportunity and a differentiator; this is the first time management has named customer reluctance as a reason a segment's margin is not improving. | “they've expressed, I will say, decidedly more caution in the adoption of AI and other automation tools” | 1994106528 | 12 |
| The procurement-environment language hardened. Prior calls described awards 'pushing to the right' as a timing dynamic with a silver lining for incumbents; the latest call adds an explicit staffing shortage and rising protests as compounding causes, while still asserting momentum is building. | “On the federal side, particularly in civilian agencies, the shortage of acquisition professionals continues to make forecasting procurement time lines difficult. In an environment where awards have shifted right, protests have increased, further delaying outcomes.” | 1994106528 | 3 |
| Buyback language moved from 'opportunistic' — the standing formulation on every prior call — to an explicit valuation judgment. Management is now saying it believes the shares are mispriced, not merely that it buys when conditions allow. | “To be more direct, we prioritize repurchasing when we believe our share price does not reflect the intrinsic value of the business based on a disciplined and conservative assessment.” | 1994106528 | 2 |
| Superlative framing has receded. The August 2025 call opened on record results and 24% year-over-year EPS growth; the FY2026 calls open on consistency, visibility and durability, with growth arguments deferred to FY2027. The tone change tracks the revenue trajectory rather than the earnings trajectory. | “I'm excited to share another record-breaking quarter for Maximus earnings.” | 1952985177 | 2 |
| Durability is now the operative claim on margins. Management is asserting that the technology-driven gains are structural rather than volume-driven, which is what justifies raising the near-term target range while revenue is flat. | “Much of the improvement has come from technology enhancements and cost discipline that we believe have staying power.” | 1994106528 | 2 |
Across twelve calls the earnings line has consistently outrun the top line, and the latest call extends that: the third consecutive year of margin-led guidance raises against revenue that management itself describes as holding within a range. The debate the transcripts sharpen is whether the technology leverage that took federal segment margin from 12.2% to a ~17.5% guide can travel to U.S. Services, where management has now given four specific reasons it cannot travel quickly. Everything on the growth side — HR-1 conversion, the VA recompete, the pipeline — sits in FY2027, and the awards data has not yet moved.